Jung, Sun Min <br/><br/>
Cytochrome P450 3A inhibitor itraconazole affects plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Nov 2005 
 - 520-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0009-9236 
<br/><br/><label>Standard No.: </label>10.1016/j.clpt.2005.07.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antifungal Agents--adverse effects<br/>Antipsychotic Agents--pharmacokinetics<br/>Chromatography, High Pressure Liquid<br/>Cytochrome P-450 CYP3A--genetics<br/>Cytochrome P-450 CYP3A Inhibitors<br/>Dose-Response Relationship, Drug<br/>Drug Interactions<br/>Enzyme Inhibitors--adverse effects<br/>Female<br/>Genotype<br/>Half-Life<br/>Humans<br/>Isoxazoles--blood<br/>Itraconazole--adverse effects<br/>Male<br/>Middle Aged<br/>Paliperidone Palmitate<br/>Psychiatric Status Rating Scales<br/>Pyrimidines--blood<br/>Risperidone--blood<br/>Schizophrenia--blood